[144] SI-BONE, Inc. SEC Filing

Rhea-AI Filing Summary

Nature's Sunshine Products, Inc. (NATR) – Form 144 filing overview

Richard D. Moss, acting through his Revocable Trust, has filed a Form 144 indicating an intent to sell 3,500 shares of NATR common stock. The proposed sale will be executed through Wells Fargo Clearing Services on or about 07 July 2025. At the filing date, the shares carry an aggregate market value of $54,986.51, implying a reference price of roughly $15.71 per share. The company reports 18,350,801 shares outstanding, so the prospective transaction represents approximately 0.02 % of the float.

Acquisition background

• The 3,500 shares were acquired on 06 May 2024 through restricted-stock grants and compensation issued by the company.

Prior insider activity (last 3 months)

• The same filer and related entities have already sold 42,734 shares between 09 May 2025 and 03 July 2025.
• Cumulative gross proceeds from those sales total ≈ $620,000 (per individual line items in the filing).

Key takeaways for investors

• The filing signals the insider’s intention to continue reducing exposure after a series of sizable disposals.
• Although the upcoming block is small relative to total shares outstanding, persistent insider selling can be interpreted by the market as a potential negative sentiment indicator.

Insights

Securities Analyst

TL;DR – Continued insider selling; modest size but persistent trend is worth noting.

The Moss Revocable Trust’s new Form 144 adds 3,500 shares to an already active selling program (≈42.7 k shares over three months). Dollar value is immaterial to liquidity, yet repeated dispositions may pressure investor perception given the insider’s ongoing divestment cadence. The sale equals 0.02 % of outstanding shares and should not impact trading dynamics, but it underscores management’s willingness to monetize equity near current price levels.

Corporate Governance Expert

TL;DR – Filing is compliant; continuous selling trend could raise governance-related scrutiny.

Form 144 affirms that the seller attests to possessing no undisclosed adverse information and presumably operates under Rule 10b5-1 or similar plans. Nonetheless, sustained sales by a high-level insider/trust can provoke shareholder questions regarding long-term commitment or inside knowledge. No red flags on procedural grounds, but transparency around motives may be advisable to mitigate perception risk.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	757	13981.79	42614514	07/07/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/15/2025	Restricted Stock Units	Issuer			757	05/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DAVID & LAURA FRANCIS JOINT REV TRU/A DTD 01/03/2003 471 El Camino Real, Suite 101 Santa Clara CA 95050	Common	05/19/2025	5412	105463.64
LAURA FRANCIS 471 El Camino Real, Suite 101 Santa Clara CA 95050	Common	05/16/2025	12385	119762.95
10b5-1 Sales for DAVID & LAURA FRANCIS JOINT REV TRU/A DTD 01/03/2003 471 El Camino Real, Suite 101 Santa Clara CA 95050	Common	05/07/2025	38504	661368.55

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Nature's Sunshine (NATR) shares does the insider plan to sell?

The Form 144 covers 3,500 common shares.

What is the estimated market value of the planned sale?

The aggregate market value stated is $54,986.51.

When is the anticipated sale date for the 3,500 NATR shares?

The approximate sale date listed is 07 July 2025.

How many shares has the same filer sold in the past 3 months?

The filing details 42,734 shares sold between 09 May 2025 and 03 July 2025.

What percentage of outstanding shares does the proposed sale represent?

3,500 shares equal roughly 0.02 % of the company’s 18,350,801 outstanding shares.

Who is the broker handling the transaction?

Wells Fargo Clearing Services, One North Jefferson Avenue, St. Louis, MO 63103.

How were the shares originally acquired?

They were obtained on 06 May 2024 through restricted-stock grants and compensation from the issuer.